Painful Diabetic Neuropathy (PDN)

2

Review clinical trials related to Painful Diabetic Neuropathy (PDN). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

The Treatment of Painful Diabetic Neuropathy With Diet

The purpose of this clinical trial is to determine whether targeted nutritional changes can improve symptoms of painful diabetic neuropathy. Impaired blood flow to peripheral nerves-resulting in reduced oxygen delivery and subsequent nerve injury-is a well-established contributor to neuropathy. Prior studies have shown that a whole-food, plant-based diet without added oils can improve or even reverse arterial disease, suggesting a potential mechanism for enhancing nerve perfusion and function. This study is a randomized controlled trial comparing a whole-food, plant-based diet with standard pharmacologic management for painful diabetic neuropathy.

Participants needed: 40
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: AdventHealthUpdated: Apr 30, 2026Locations: 1
Eligibility criteria

Definitive diagnosis of type II diabetes mellitus (HgA1c ≥ 6.5) or pre-diabetes... [+6]

Potential causes of neuropathy other than type II diabetes mellitus (as listed b... [+11]

Status: Recruiting

Thai PainPREDICT Validation Study

Painful diabetic neuropathy (PDN) is one of the most common and disabling complications of diabetes mellitus, substantially affecting quality of life, daily functioning, and health system burden. Early identification of PDN is crucial for timely treatment, prevention of complications such as foot ulcers and amputations, and for reducing healthcare costs. However, in Thailand there are limited culturally adapted and validated tools for screening PDN. PainPREDICT is an internationally validated questionnaire designed to characterize neuropathic pain profiles, but its adaptation for Thai patients has not yet been undertaken. In parallel, the use of mobile health technologies (mHealth) has the potential to expand access to screening and monitoring of chronic conditions, particularly in resource-limited settings.

Participants needed: 277
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Chulalongkorn UniversityUpdated: Oct 3, 2025Locations: 1
Eligibility criteria

Adults aged 18 years or older. [+3]

Presence of neuropathy due to other causes (e.g., alcohol, chemotherapy, HIV, ot... [+2]